Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAGLAZYME vs NALBUPHINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAGLAZYME vs NALBUPHINE: Safety Overview

Metric NAGLAZYME NALBUPHINE
Total FAERS Reports 414 702
Deaths Reported 18 78
Death Rate 4.3% 11.1%
Hospitalizations 88 95
Average Patient Age 12.2 yrs 42.1 yrs
% Female Patients N/A 63.5%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Henry Schein, Inc.
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued